Princeton Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,153
| Closed | -$888K | – | 96 |
|
|
2023
Q2 | $888K | Sell |
22,153
-1,350
| -6% | -$54.1K | 0.37% | 46 |
|
|
2023
Q1 | $959K | Sell |
23,503
-773
| -3% | -$31.5K | 0.41% | 47 |
|
|
2022
Q4 | $937K | Sell |
24,276
-1,174
| -5% | -$45.3K | 0.42% | 49 |
|
|
2022
Q3 | $1.35M | Buy |
25,450
+911
| +4% | +$48.5K | 0.59% | 38 |
|
|
2022
Q2 | $1.43M | Sell |
24,539
-367
| -1% | -$21.4K | 0.55% | 43 |
|
|
2022
Q1 | $1.9M | Sell |
24,906
-335
| -1% | -$25.6K | 0.59% | 40 |
|
|
2021
Q4 | $1.52M | Buy |
25,241
+917
| +4% | +$55.2K | 0.44% | 50 |
|
|
2021
Q3 | $1.36M | Buy |
24,324
+979
| +4% | +$54.8K | 0.43% | 51 |
|
|
2021
Q2 | $1.42M | Buy |
23,345
+834
| +4% | +$50.6K | 0.44% | 48 |
|
|
2021
Q1 | $1.58M | Buy |
22,511
+362
| +2% | +$25.4K | 0.53% | 46 |
|
|
2020
Q4 | $1.33M | Buy |
22,149
+500
| +2% | +$29.9K | 0.47% | 49 |
|
|
2020
Q3 | $1.3M | Buy |
21,649
+901
| +4% | +$54.2K | 0.52% | 47 |
|
|
2020
Q2 | $1.09M | Buy |
20,748
+4,862
| +31% | +$255K | 0.48% | 46 |
|
|
2020
Q1 | $663K | Sell |
15,886
-3,794
| -19% | -$158K | 0.34% | 51 |
|
|
2019
Q4 | $931K | Sell |
19,680
-1,219
| -6% | -$57.7K | 0.42% | 46 |
|
|
2019
Q3 | $796K | Sell |
20,899
-29
| -0.1% | -$1.11K | 0.39% | 47 |
|
|
2019
Q2 | $910K | Buy |
20,928
+1,099
| +6% | +$47.8K | 0.44% | 45 |
|
|
2019
Q1 | $755K | Sell |
19,829
-1,549
| -7% | -$59K | 0.38% | 47 |
|
|
2018
Q4 | $920K | Sell |
21,378
-6,390
| -23% | -$275K | 0.54% | 39 |
|
|
2018
Q3 | $1.37M | Sell |
27,768
-571
| -2% | -$28.1K | 0.57% | 36 |
|
|
2018
Q2 | $908K | Sell |
28,339
-210
| -0.7% | -$6.73K | 0.39% | 44 |
|
|
2018
Q1 | $889K | Sell |
28,549
-489
| -2% | -$15.2K | 0.39% | 45 |
|
|
2017
Q4 | $1.33M | Buy |
+29,038
| New | +$1.33M | 0.59% | 38 |
|